Comparison of Telehomecare Interventions in Controlling Chronic Obstructive Pulmonary Disease (COPD): Protocol for a Systematic Review and Meta-analysis

  • Zohreh Shoyukhi MSc student of Health Technology Assessment ,Consultation Center for Secondary Researches, Data Mining, and Knowledge Transfer in Health and Medical Sciences, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  • Arezoo Dehghani Mahmoodabadi Health Information Management, Department of Health Information Technology and Management, Health Technology Assessment and Medical Informatics Research Center, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  • Hamid Reza Dehghan Health Information Management, Department of Health Information Technology and Management, Health Technology Assessment and Medical Informatics Research Center, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
Keywords: Telemedicine, Chronic Obstructive Pulmonary Disease, Meta-Analysis, Systematic Review

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is considered the fourth main cause of mortality worldwide, affecting 10% of adults aged up to 40 years. Due to the growing elderly population and smoking, the global burden of COPD is expected to increase in the general population. Telemedicine may help patients with COPD to decrease exacerbation episodes and the associated costs. Moreover, Telehomecare (THC) may be considered as an alternative to cut down hospitalization costs and increase the patients’ comfort.

Objectives: This study explains the methodology of a systematic review and meta-analysis designed to evaluate the impact of THC interventions on the control and management of COPD and its complications.

Methods: To review all published studies comparing THC interventions in controlling COPD and its complications, all studies published in PubMed, Google Scholar, Scopus, ISI Web of Science, Cochrane databases, HTA EED, DARE, Embase, SID, Magiran will be searched until the end of 2021.  Randomized controlled trials (RCTs), cluster RCTs, controlled clinical trials comparing telehealth with standard monitoring of COPD patients were included. Independent reviewers will review the abstracts and full-texts of all relevant studies for eligibility, risk of bias, and data extraction using structured forms. The meta-analysis will be performed for adequately homogenous studies regarding their populations, interventions, and objectives.

Conclusion: The results of this systematic review and meta-analysis will provide useful information on the impacts of THC on COPD control. The evidence provided by this systematic review can be helpful for clinical specialists, public health policymakers, and the general population.

Published
2021-10-12
Section
Articles